Cochrane Summariesbeta

Independent high-quality evidence for health care decision making

Intravesical doxorubicin versus epirubicin for superficial bladder cancer

Dong Z-L, Yang K, Liu Y, Mi DH, Wang ZP, Tian J
Published Online: 
May 11, 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to compare the effectiveness and safety of doxorubicin and epirubicin for Ta and T1 bladder cancer.

Find the research
Get full text at The Cochrane Library
Primary Review Group: 
Prostatic Diseases and Urologic Cancers Group

More like this